Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Venture Capital

Bain Capital Leads $70M Round In Biotech Company

by posted 2years ago 396 views
Dicerna Pharmaceuticals Inc, a maker of RNAi therapeutics, has secured $70 million in convertible preferred stock financing. Bain Capital Life Sciences was the lead investor. Other participants in the financing included EcoR1 Capital, Cormorant Asset Management, RA Capital, Domain Associates and Skyline Ventures. In conjunction with the funding, Dr. Adam M. Koppel, a managing director at Bain Capital Life Sciences, has been added to Dicerna’s board of directors.